RareResearch.AI
← Back to atlas

S353F

Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource card
SerinePhenylalanine at position 353 · Transmembrane helix 2 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type S353 — hydrogen bond to M357
Fullscreen ↗
DynaMut2 mutant · S353F
Mutant F353 — hydrogen bond to I349 lost (3 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

3 lost15 gained9 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondI349I349Preserved
Hydrogen bondF350F350Preserved
Hydrogen bondS356S356Preserved
Hydrogen bondM357M357Preserved
Hydrogen bondS411S411Preserved
Polar contactI349I349Preserved
Polar contactF350F350Preserved
Polar contactY351Gained
Polar contactI355Gained
Polar contactS356S356Preserved
Polar contactM357M357Preserved
Polar contactS411Gained
Polar contactV415Lost
Aromatic / πF414Gained
CarbonylS356Gained
Van der WaalsI349Lost
Van der WaalsF350Gained
Van der WaalsY351Gained
Van der WaalsS356Gained
Van der WaalsS411Gained
Van der WaalsF414Gained
Van der WaalsV415Lost
HydrophobicI349Gained
HydrophobicF414Gained
HydrophobicV415Gained
HydrophobicL637Gained
HydrophobicL640Gained

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.58kcal/mol
Destabilising — mild
AlphaMissense
0.983
likely pathogenic
AlphaFold pLDDT
94
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable
ΔΔG confidence: Reduced confidence · Transmembrane
  • transmembrane position; predictor benchmarked on soluble proteins

This variant sits in the transmembrane band. The stability value was computed with a predictor benchmarked on water-soluble proteins. Published benchmarks of ddG predictors on membrane proteins report correlation below 0.4. Treat the magnitude as unreliable and the sign as weak evidence only.

Do not rank this value against a variant from a different region on ΔΔG alone.

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Low frequency · AF 0.020%
cDNA changec.1058C>T
ClinVar accessionVCV003720567
Last evaluated2024/03/23 00:00

Observed in the general population.

Classified for1★ unverified submission

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 1★ single submitter. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
AF 0.020% · 329 / 1,612,198 alleles
Homozygotes
0
Highest-frequency population
European (non-Finnish) · AF 0.026%

Highest in European (non-Finnish): AF 0.026% (307 of 1,179,868 alleles), in line with the global figure.

No homozygotes reported in gnomAD v4. For a recessive allele this is expected and is not, on its own, evidence either way.

Ancestry groupAllele freq.AC / ANHom.Carrier est.
European (non-Finnish)0.026%307 / 1,179,8680~1 in 1920
Remaining individuals0.018%11 / 62,4880~1 in 2840
Admixed American0.015%9 / 60,0320~1 in 3340
Finnish · under-sampled0.0016%1 / 62,2180
African / African American · under-sampled0.0013%1 / 75,0600

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Full Variant Card

WFS1 Wolframin — S353F Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Serine → Phenylalanine at position 353. Transmembrane helix 2. ClinVar Uncertain significance, AlphaMissense 0.983, DynaMut2 ΔΔG -0.58 kcal/mol (destabilising).


Identity

FieldValue
VariantS353F (p.Serine353Phenylalanine)
DNA changec.1058C>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV003720567
Amino acid changeSerine (S) → Phenylalanine (F)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 35393.75 — well-folded
DomainTransmembrane helix 2
Position contextInside Transmembrane helix 2 · position 353 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 353 sits in a transmembrane helix (Transmembrane helix 2). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is small polar (serine — hydroxyl); the mutant is large aromatic hydrophobic (phenylalanine). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.9832
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-0.58 (Destabilising)
Job ID178092092726
Result URLJob 178092092726 · retrieved 2026-06-08 — result self-hosted by RareResearch.AI (Biosig no longer serves this page)

Clinical Evidence

Inheritance and scope

Uncertain significance — phenotype scope not stated in ClinVar

ClinVar classifies this variant as Uncertain significance, but does not state what it is classified for. ClinVar records no condition for this variant. A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient. Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2024/03/23 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeS353F is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.58 < 2 kcal/mol (fold intact) + AlphaMissense 0.983 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.58 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.983. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • S353F_molstar_viewer.html — interactive 3D viewer (auto-highlights position 353 with ball-and-stick + neighbors within 5Å)
  • S353F_variant_card.md — this card (source of truth)
  • S353F_variant_card.html — styled printable card
  • S353F_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • S353F_wildtype_interactions.pse / S353F_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the S353F PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download S353F PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.